Ra Medical Systems, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RMED research report →
Companywww.ramed.com
Ra Medical Systems, Inc. , a medical device company, develops, manufactures, and markets excimer lasers for use in the treatment of vascular immune-mediated inflammatory diseases. It offers destruction of arteriosclerotic blockages by laser radiation ablation, a minimally invasive excimer laser and single-use catheter system that is used by physicians in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease.
- CEO
- David A. Jenkins
- IPO
- 2018
- Employees
- 14
- HQ
- Carlsbad, CA, US
Price Chart
Valuation
- Market Cap
- $3.84M
- P/E
- -80.47
- P/S
- 4.46
- P/B
- 136.06
- EV/EBITDA
- -0.77
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 117.91%
- Op Margin
- -2330.23%
- Net Margin
- -1881.28%
- ROE
- -214.33%
- ROIC
- -85.66%
Growth & Income
- Revenue
- $819.00K · 95.00%
- Net Income
- $-17,183,000 · 21.18%
- EPS
- $-15.90 · -138.02%
- Op Income
- $-21,080,000
- FCF YoY
- 10.98%
Performance & Tape
- 52W High
- $11.13
- 52W Low
- $0.48
- 50D MA
- $0.70
- 200D MA
- $2.07
- Beta
- 0.00
- Avg Volume
- 290.93K
Get TickerSpark's AI analysis on RMED
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jan 19, 24 | JENKINS DAVID A | buy | 8,470 |
| Jan 18, 24 | JENKINS DAVID A | buy | 8,470 |
| Jan 16, 24 | JENKINS DAVID A | buy | 8,470 |
| Jan 16, 24 | JENKINS DAVID A | buy | 7,793 |
| Jan 8, 24 | Francis, John P. | other | 25,000 |
| Jan 2, 24 | Francis, John P. | other | 0 |
| Jan 2, 24 | Francis, John P. | other | 0 |
| Jan 2, 24 | Francis, John P. | other | 11,481 |
| Aug 3, 20 | Francis, John P. | other | 1,371 |
| May 22, 20 | Francis, John P. | other | 177 |
Our RMED Coverage
We haven't published any research on RMED yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate RMED Report →